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Table 1. Search strategies. 
Database Strategy 
 
Allied and Complementary 
Medicine (AMED) (through 
OVID) 
 
S1: meditation/   
S2: mindful*.mp.  
S3: meditat*.mp.  
S4: clinical trials/ or randomized controlled trials/ or double blind method/ or random 
allocation/ 
S5: RCT.mp.  
S6: (random* adj1 allocat*).mp.  
S7: (random* adj1 assign*).mp.  
S8: randomis*.mp.  
S9: randomiz*.mp.  
S10: 1 or 2 or 3  
S11: 4 or 5 or 6 or 7 or 8 or 9  
S12: 10 and 11  
 
Applied Social Sciences 
Index and Abstracts (ASSIA) 
 
S1: ab((mindful* OR meditat*) AND (randomise* OR randomize* OR RCT OR "random 
allocation" OR "random assignment")) OR ti((mindful* OR meditat*) AND (randomise* 
OR randomize* OR RCT OR "random allocation" OR "random assignment")) 
 
Cochrane Central Register of 
Controlled Trials (CENTRAL) 
 
S1: MH “Mindfulness” 
S2: AB (mindfulness or mindfulness or meditat*) or TI (mindfulness or mindfulness or 
meditat*) 
1 or 2 
 
Cumulative Index to Nursing 
and Allied Health Literature 
(CINAHL) (through EBSCO) 
 
S1: (MH "Mindfulness+")  
S2: (MH "Mindfulness")  
S3: (MH "Meditation")  
S4: TI (mindful* OR meditat*) OR AB (mindful* OR meditat*)  
S5: S1 OR S2 or S3 or S4  
S6: MH "Clinical Trials+"  
S7: PT Clinical trial  
S8: TX clinic* n1 trial*  
S9: TX ( (singl* n1 blind*) or (singl* n1 mask*) ) or TX ( (doubl* n1 blind*) or (doubl* 
n1 mask*) ) or TX ( (tripl* n1 blind*) or (tripl* n1 mask*) ) or TX ( (trebl* n1 blind*) or 
(trebl* n1 mask*) )  
S10: TX randomi* control* trial*  
S11: (MH "Random Assignment")  
S12: TX random* allocat*  
S13: TX placebo*  
S14: (MH "Placebos")  
S15: (MH "Quantitative Studies")  
S16: TX allocat* random*  
S17: S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16  
S18: S5 AND S17  
 
Excerpta Medica Database 
(EMBASE) (through OVID) 
 
S1  exp meditation/ or exp mindfulness/ 
S2  (mindfullness or mindfulness or meditat*).ab. or (mindfullness or mindfulness or 
meditat*).ti. 
S3  1 or 2 
S4  clinical trial/ 
S5  randomized controlled trial/ 
S6  controlled clinical trial/ 
S7  multicenter study/ 
S8  phase 3 clinical trial/ 
S9  phase 4 clinical trial/ 
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S10 double blind procedure/ 
S11 placebo/ 
S12 exp randomization/ 
S13 (randomi?ed controlled trial$ or rct or (random$ adj2 allocat$) or single blind$ or 
double blind$ or ((treble or triple) adj blind$) or placebo$).tw. 
S14 Prospective Study.mp. or prospective study/ 
S15 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 
S16 3 and 15  
 
Education Resources 
Information Center (ERIC) 
(through EBSCO) 
 
S1: AB (meditat* OR mindful*) OR TI (meditat* OR mindful*)  
S2: randomis* OR randomiz* OR RCT OR "random* allocat*" OR "random* assign*"  
S3: S1 AND S2  
 
Electronic Theses Online 
Service (EThOS) 
 
S1: Advanced search: mindful (title) AND randomise (any word) 
 
Medical Literature Analysis 
and Retrieval System Online 
(MEDLINE) (through OVID) 
 
S1: Randomized Controlled Trials as Topic/ 
S2: randomized controlled trial/ 
S3: Random Allocation/ 
S4: Double Blind Method/ 
S5: Single Blind Method/ 
S6: clinical trial/ 
S7: clinical trial, phase i.pt 
S8: clinical trial, phase ii.pt 
S9: clinical trial, phase iii.pt 
S10: clinical trial, phase iv.pt 
S11: controlled clinical trial.pt 
S12: randomized controlled trial.pt 
S13: multicenter study.pt 
S14: clinical trial.pt 
S15: exp Clinical Trials as topic/ 
S16: or/1-15 
S17: (clinical adj trial$).tw 
S18: ((singl$ or doubl$ or treb$ or tripl$) adj (blind$3 or mask$3)).tw 
S19: PLACEBOS/ 
S20: placebo$.tw 
S21: randomly allocated.tw 
S22: (allocated adj2 random$).tw 
S23: or/17-22 
S24: 16 or 23 
S25: case report.tw 
S26: letter/ 
S27: historical article/ 
S28: or/25-27 
S29: 24 not 28 
S30: exp meditation/ or exp mindfulness/ 
S31: (mindfulness or mindfulness or meditat*).ab or (mindfulness or mindfulness or 
meditat*).ti 
S32: 30 or 31 




S1: ab((mindful* OR meditat*) AND (randomise* OR randomize* OR RCT OR "random 
allocation" OR "random assignment")) OR ti((mindful* OR meditat*) AND (randomise* 
OR randomize* OR RCT OR "random allocation" OR "random assignment")) 
 
PsycINFO (through EBSCO) 
 
S1: DE "Meditation" OR DE "Mindfulness"  
S2: AB (mindfullness OR mindfulness OR meditat* OR mindful*) OR TI (mindfullness 
OR mindfulness OR meditat* OR mindful*) 
S3: S1 OR S2  
S4: AB ((randomized controlled trial) OR (Random Allocation) OR (Double Blind 
Method) OR (Single Blind Method) OR (clinical trial) OR (clinical trial, phase i.pt) OR 
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(clinical trial, phase ii.pt) OR (clinical trial, phase iii.pt) OR (clinical trial, phase iv.pt) 
OR (controlled clinical trial.pt) OR (randomized controlled trial.pt) OR (multicenter 
study.pt) OR (clinical trial.pt) OR ((clinical adj trial$).tw) OR (((singl$ or doubl$ or 
treb$ or tripl$) adj (blind$3 or mask$3)).tw) OR PLACEBOS OR (placebo$.tw) OR 
(randomly allocated.tw) OR ((allocated adj2 random$).tw)) OR TI ( (randomized 
controlled trial) OR (Random Allocation) OR (Double Blind Method) OR (Single Blind 
Method) OR (clinical trial) OR (clinical trial, phase i.pt) OR (clinical trial, phase ii.pt) OR 
(clinical trial, phase iii.pt) OR (clinical trial, phase iv.pt) OR (controlled clinical trial.pt) 
OR (randomized controlled trial.pt) OR (multicenter study.pt) OR (clinical trial.pt) OR 
((clinical adj trial$).tw) OR (((singl$ or doubl$ or treb$ or tripl$) adj (blind$3 or 
mask$3)).tw) OR PLACEBOS OR (placebo$.tw) OR (randomly allocated.tw) OR 
((allocated adj2 random$).tw))  




S1: (mindful* OR meditat*) AND (randomise* OR randomize* OR RCT OR "random 
allocation" OR "random assignment") 
 
Web of Science 
 
S1: advanced search: TS=((mindful* OR meditat*) AND (randomise* OR randomize* 
OR RCT OR "random allocation" OR "random assignment")) 
 
World Health Organization 
(WHO) International Clinical 
Trials Registry Platform 
(ICTRP) 
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Table 2. Pre-piloted extraction forms. 
Form Tab Information collected 
Study Identification Sponsorship sources, conflicts of interest, country, study setting, corresponding authors, 
institution, emails, date recruitment started, and year first published. 
Methods Study design, conceptualisation of mindfulness, incentives for participants, number of 
participants (total randomised and per arm), and power calculation.  
Population Inclusion and exclusion criteria, type of participant, group differences, baseline 
characteristics 
Interventions Intervention name, mention of intervention manual, whether it was an adaptation of 
another intervention (rationale), intensity, mindfulness components (type, frequency 
and duration), non-mindfulness components (type, frequency and duration), home 
practice length and type, group size, any individual tailoring, any booster sessions or 
support after the end of the programme, adherence to intervention manual, intervention 
setting, teacher competence, teacher characteristics, response to intervention 
(attendance, satisfaction, reasons for missing sessions), and whether participants paid to 
do the course. 
Outcomes Outcome measure used, time points, group sizes, effect measures available and extracted 
effect sizes.  
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Table 3. Definitions to refine primary outcome selection. 
Primary outcome Requirement 
Distress has to measure more than one negative emotion 
Wellbeing has to be more than one positive emotion 
Anxiety has to include physical symptoms and functioning impairment. 
Depression has to include general anhedonia, worthlessness, physical symptoms and functioning 
  





Table 4 contains a summary of secondary outcome results, which are summarised below. The 
systematic review search date for the secondary outcomes was January 2020. 
Comparison with passive control groups 
At post-intervention (measured within one month of completing the intervention), in comparison 
with passive control groups, on average MBPs improved anxiety, depression, psychological 
distress, and mental wellbeing, (Table 6). The prediction intervals indicated that post-intervention 
anxiety will be reduced following MBPs in more than 95% of the scenarios, but improvement is 
not homogeneous for the rest of the outcome domains. There was no evidence that improvements 
following MBPs in depression, distress or wellbeing remained six or more months post-
intervention (no studies for anxiety). However, only one study measured depression, four distress 
and three wellbeing at six or more months post-intervention, so results need to be interpreted with 
caution. 
There is evidence for a modest and heterogeneous improvement in cognitive functioning following 
MBPs compared to passive controls shortly after intervention completion, with no significant 
differences at one-to-six-months follow-up (Table 9). MBPs improved real-life functioning at 
post-intervention in comparison with passive controls (small effect, Table 12). Effects may last for 
up to six months, with no reliable evidence on longer effects. MBPs improved the relationship 
with the self for up to at least six months (Table 15, no data on longer-term outcomes), and 
dispositional mindfulness for longer (Table 22). MBPs reduced psychosomatic symptoms shortly 
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after course completion (Table 18), but no evidence supported effects persisting for any longer 
(Table 19). None of these effects was generalisable across settings. 
Comparison with active non-specific control groups 
In comparison with active non-specific control groups at post-intervention, results supported 
improvements following MBPs in anxiety, depression, distress and wellbeing. However, reliability 
is low due to a mix of few studies contributing data, borderline p values, and prediction intervals 
that included adverse scenarios (Table 7). No studies measured these outcomes six or more months 
after the interventions. We found no evidence for improvements following MBPs in cognitive 
function (only three studies measuring this, Table 10), real-life functioning (only four studies 
measuring it, Table 13), psychosomatic outcomes (only 2 studies measuring it, Table 20), or 
dispositional mindfulness (Table 23). MBPs improved the relationship with the self for up to at 
least six months (Table 16, no data on longer-term outcomes). However, this effect is not 
generalisable to all implementation settings. 
Comparison with active specific control groups 
Compared with active specific control groups, findings supported a modest superiority of MBPs 
in improving depression and wellbeing, but not distress and anxiety, at post-intervention (Table 
8). Prediction intervals included null or unfavourable effects. Very few studies measured these 
outcomes six or more months after the intervention, with no significant differences between 
groups. We found no evidence for improvement in cognitive functioning (Table 11), real-life 
functioning (Table 14), relationship with the self (Table 17), psychosomatic symptoms (Table 21), 
or dispositional mindfulness (Table 24). 
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Risk-of-bias Source-specific Sensitivity Analyses 
Source-specific sensitivity analyses could be conducted for risk-of-bias sources of randomisation, 
deviations from intended interventions, and missing outcome data; there was not enough risk 
variance for the other sources to meaningfully remove higher-risk trials. Source-specific analyses 
gave similar results to the overall-risk sensitivity analyses, except that in the comparison with 
passive controls the effects of MBPs on depression, distress and wellbeing remained significant 
and with narrower prediction intervals after removing trials at high risk of bias due to deviations 
from the intended interventions (a bias that tended to dilute intervention effects due to 
contamination between arms, Table 31). 
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SMD (95%CI) p 95%PI Missed 
trials* 
Passive Anxiety P-int 19 -0.70 (-0.85, -0.54), <0.001 -1.29, -0.10 0 
 Depression P-int 37 -0.45 (-0.57, -0.33), <0.001 -1.04, 0.14 1 (3%) 
 Depression 6+m 1 -0.19 (-0.78, 0.40), 0.53 -1.02, 0.64 0 
 Distress P-int 61 -0.45 (-0.54, -0.36), <0.001 -1.03, 0.14 4 (6%) 
 Distress 6+m 4 -0.16 (-0.48, 0.15), 0.31 -0.82, 0.50 0 
 Wellbeing P-int 25 0.34 (0.21 0.48), <0.001 -0.25, 0.94 3 (11%) 
 Wellbeing 6+m 3 0.25 (-0.10, 0.60), 0.17 -0.43, 0.93 1 (25%) 
 Cog. Func. P-int 13 0.25 (0.06, 0.44) , 0.009 -0.32, 0.83 1 (7%) 
 Cog. Func. 1-6m 2 0.03 (-0.52, 0.58) , 0.91 -1.04, 1.10 1 (33%) 
 Real Func. P-int 25 0.27 (0.12, 0.43), <0.001 -0.38, 0.93 1 (4%) 
 Real Func. 1-6m 14 0.23 (0.05, 0.40), 0.013 -0.44, 0.89 1 (7%) 
 Real Func. 6+m 1 0.09 (-0.56, 0.74), 0.79 -0.85, 1.02 1 (50%) 
 Rel. Self P-int 20 0.77 (0.47, 1.07), <0.001   -0.60, 2.13 2 (10%) 
 Rel. Self 1-6m 8 0.71 (0.41, 1.02), <0.001 -0.38, 1.80 0 
 Psychosom. P-int 14 -0.41 (-0.58, -0.24), <0.001 -0.94, 0.12 1 (7%) 
 Psychosom. 1-6m 7 -0.25 (-0.65, 0.16), 0.19 -1.27, 0.78 1 (13%) 
 Mindfulness P-int 50 0.54 (0.41, 0.67), <0.001 -0.35, 1.42 5 (9%) 
 Mindfulness 1-6m 18 0.56 (0.40, 0.72), <0.001 -0.33, 1.45 2 (10%) 




Anxiety P-int 4 -0.55 (-0.95, -0.15), 0.007 -1.69, 0.58 1 (20%) 
Depression P-int 7 -0.43 (-0.77, -0.08), 0.016 -1.53, 0.68 0 
Distress P-int 9 -0.38 (-0.70, -0.06), 0.021 -1.48, 0.72 1 (10%) 
 Wellbeing P-int 1 3.00 (1.70, 4.30), <0.001 1.18, 4.83 0 
 Cog. Func. P-int 3 0.08 (-0.66, 0.81), 0.84 -8.82, 8.98 0 
 Real Func. P-int 3 0.04 (-0.75, 0.83), 0.92     -3.18, 3.26 0 
 Real Func. 1-6m 2 0.12 (-0.87, 1.12), 0.81 -3.36, 3.60 0 
 Rel. Self P-int 3 0.80 (0.26, 1.34), 0.004      -1.49, 3.09 0 
 Rel. Self 1-6m 3 0.73 (0.18, 1.28), 0.010      -1.58, 3.03 0 
 Psychosom. P-int 2 -0.36 (-0.74, 0.03), 0.067       NA 0 
 Psychosom. 1-6m 1 -0.29 (-0.89, 0.30), 0.34     NA 0 
 Mindfulness P-int 7 0.21 (-0.02, 0.44), 0.068     -0.42, 0.85 0 
 Mindfulness 1-6m 6 0.28 (-0.06, 0.61), 0.11     -0.44, 0.99 0 
Active 
specific 
Anxiety P-int 7  -0.12 (-0.27, 0.04), 0.14 -0.45, 0.21 1 (13%) 
Depression P-int 17  -0.24 (-0.36, -0.13),  <0.001 -0.55, 0.07 0 
Depression 6+m 3  -0.05 (-0.33, 0.24), 0.75 -0.46, 0.37 0 
 Distress P-int 24  -0.07 (-0.18, 0.03), 0.15 -0.38, 0.23 5 (17%) 
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 Distress 6+m 4  -0.03 (-0.27, 0.22), 0.84 -0.41, 0.36 0 
 Wellbeing P-int 10  0.17 (0.03, 0.31), 0.015 -0.15, 0.49 3 (23%) 
 Wellbeing 6+m 1  -0.00 (-0.36, 0.36), 0.99 -0.48, 0.47 1 (50%) 
 Cog. Func. P-int 7  -0.03 (-0.29, 0.24), 0.80 -0.47, 0.41 0 
 Real Func. P-int 6 0.03 (-0.17, 0.23), 0.76      -0.21, 0.27 1 (14%) 
 Real Func. 1-6m 4 0.01 (-0.21, 0.23), 0.93     -0.26, 0.28 1 (20%) 
 Real Func. 6+m 3 0.02 (-0.18, 0.23), 0.82      -0.22, 0.27 0 
 Rel. Self P-int 6 0.13 (-0.15, 0.41), 0.37     -0.53, 0.78 3 (33%) 
 Rel. Self 1-6m 1 0.40 (-0.12, 0.92), 0.13     -0.47, 1.27 1 (50%) 
 Rel. Self 6+m 1 0 .00 (-0.90, 0.90), 1.00 -1.30, 1.30 1 (50%) 
 Psychosom. P-int 7 -0.18 (-0.38, 0.02), 0.068     -0.72, 0.36 1 (13%) 
 Psychosom. 1-6m 4 -0.13 (-0.36, 0.09), 0.25     -0.70, 0.43 2 (33%) 
 Psychosom. 6+m 2 -0.15 (-0.42, 0.13), 0.29     -0.74, 0.45 0 
 Mindfulness P-int 19 0.14 (-0.02, 0.29), 0.09      -0.49, 0.76 2 (10%) 
 Mindfulness 1-6m 7 0.12 (-0.07, 0.31), 0.20     -0.52, 0.76 1 (13%) 
 Mindfulness 6+m 3 0.15 (-0.09, 0.40), 0.21     -0.51, 0.81 1 (25%) 
* Number of trials with non-reported data for the corresponding outcome. Abbreviations: 1-6m=1 to 6 months post-
intervention follow up, 6+ months= more than 6 months post intervention follow up, CI= confidence interval for overall 
mean, Cog. Func = Cognitive functioning, n=number, P-int=post-intervention, PI= prediction interval for new study, 
Psychosom = Psychosomatic outcomes, Real func = Real life functioning, Rel. Self = Relationship with self, 








Table 5. Conference abstracts for which too much information was missing to assess eligibility. 
1 Siwik, C., Phillips, K., Salmon, P., Litvan, I., Filoteo, V., Rebholz, W., ... & van der Gryp, K. (2018, April). An MBSR 
intervention for parkinson’s disease patients and caregiving partners: Effects on distress, social support, cortisol, 
and inflammation. In Psychosomatic Medicine (Vol. 80, No. 3, pp. A128-A128). Two Commerce SQ, 2001 Market St, 
Philadelphia, PA 19103 USA: Lippincott Williams & Wilkins.  
 
2 Greven, C.; Bogels, S.; Dammers, J.; Buitelaar, J.; Speckens, A. Mindfulness for children with ADHD and Mindful 
Parenting (MindChamp): a randomised controlled trial. Journal of Neural Transmission Nov 2019;126(11):1568-
1569 2019 Nov 
 
3 Orosa Duarte, A.; Mediavilla, R.; Lopez Herrero, V.; Garde Gonzalez, J.; Rodriguez Vega, B.; Munoz San Jose, A.; Palao 
Tarrero, A.; Bravo Ortiz, M. F.; Bayon Perez, C. Mindfulness-based intervention through a smartphone application 
versus mindfulness-based stress reduction (MBSR) program in healthcare students: a randomised controlled trial. 
European Psychiatry Apr 2019;56():S569-S569 2019 Apr 
 
4 Exploring effects of aerobic exercise and mindfulness training on cognitive function in older adults at risk of 
dementia: The active minds study. Circulation 2018;138(Supplement 1): Netherlands Lippincott Williams and 
Wilkins 2018 
 
5 Wang, Z. Y.; Jin, Z. The Effects of mindfulness-based cognitive therapy (MBCT) on anxiety and depression among 
professional women: Increased EEG gamma and alpha brainwave amplitude. Basic and Clinical Pharmacology and 
Toxicology 2018;123(Supplement 3):103 Netherlands Blackwell Publishing Ltd 2018 
 
6 Kiseleva, N.; Kiselev, S. Mindfulness training can reduce prenatal maternal stress. Journal of the Neurological 
Sciences 2019;405(Supplement):32 Netherlands Elsevier B.V. 2019 
 
7 Kiselev, S.; Volik, I. Influence of mindfulness training on stress reduction during pregnancy. European Psychiatry 














Variance-covariance matrix = proportional .9*I(11)+.1*J(11,11,1) 
Method = reml                                  Number of dimensions    =    11 
Restricted log likelihood = -119.78835         Number of observations  =    78 
 
 Coef. Std. 
Err. 
z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int anxiety -.694 .081 -8.54 0.000 -.854 -.535 
1-6m anxiety -.563 .120 -4.68 0.000 -.799 -.327 
Post-int depression -.450 .061 -7.32 0.000 -.571 -.330 
1-6m depression -.533 .096 -5.53 0.000 -.722 -.344 
+6m depression -.190 .301 -0.63 0.526 -.780  .399 
Post-int distress -.446 .046 -9.62 0.000 -.537 -.355 
1-6m distress -.447 .068 -6.54 0.000 -.581 -.313 
+6m distress -.163 .162 -1.01 0.314 -.480  .154 
Post-int wellbeing  .343 .069  4.94 0.000  .206  .479 
1-6m wellbeing  .325 .110  2.94 0.003  .108  .542 
+6m wellbeing  .248 .179  1.39 0.165 -.102  .599 
 
  
Table 6. Comparison of MBPs with passive control groups: multivariate meta-analysis of anxiety, depression, 
distress, and wellbeing outcomes at post-intervention, (post-int), 1-6 months follow-up, (1-6m) and 6+ months follow-
up (+6m). Exchangeable between-study variance-covariance matrices (0.1). 











Variance-covariance matrix = proportional .3*I(8)+.7*J(8,8,1) 
Method = reml                                  Number of dimensions    =     8 
Restricted log likelihood = -23.495745         Number of observations  =    11 
 
 Coef. Std. 
Err. 
z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int anxiety -.552 .204 -2.70 0.007 -.953 -.151 
1-6m anxiety -.474 .201 -2.35 0.019 -.869 -.079 
Post-int depression -.426 .176 -2.42 0.016 -.772 -.080 
1-6m depression -.454 .180 -2.52 0.012 -.808 -.101 
Post-int distress -.378 .164 -2.30 0.021 -.700 -.056 
1-6m distress -.137 .188 -0.73 0.465 -.506  .231 
Post-int wellbeing  3.006 .663  4.53 0.000 1.705 4.306 




Table 7. Comparison of MBPs with active non-specific control groups: multivariate meta-analysis of anxiety, 
depression, distress, and wellbeing at post-intervention, (post-int), 1-6 months follow-up, (1-6m) and 6+ months 
follow-up (+6m). Exchangeable between-study variance-covariance matrices (0.7). 











Variance-covariance matrix = proportional .9*I(11)+.1*J(11,11,1) 
Method = reml                                  Number of dimensions    =    11 
Restricted log likelihood = -15.552314         Number of observations  =    31 
 
 Coef. Std. 
Err. 
z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int anxiety -.116   .079   -1.46   0.143   -.272    .039 
1-6m anxiety .072    .140    0.51   0.607    -.203   .348 
Post-int depression -.241    .059   -4.06   0.000    -.358    -.125 
1-6m depression -.165   .078   -2.10   0.036   -.319    -.010 
+6m depression -.045   .143   -0.32   0.752    -.326     .235 
Post-int distress -.074   .051   -1.45   0.146    -.175    .026 
1-6m distress -.008   .073   -0.12   0.904    -.151    .134 
+6m distress -.026   .126   -0.21    0.836     -.274     .222 
Post-int wellbeing .169   .069    2.43   0.015    .032    .306 
1-6m wellbeing .028   .108    0.26   0.791    -.183     .240 
+6m wellbeing -.001   .183   -0.01   0.992    -.362    .358 
 
  
Table 8. Comparison of MBPs with active specific control groups: multivariate meta-analysis of anxiety, 
depression, distress, and wellbeing at post-intervention, (post-int), 1-6 months follow-up, (1-6m) and 6+ months 
follow-up (+6m). Exchangeable between-study variance-covariance matrices (0.1). 










Variance-covariance matrix = unstructured 
Method = reml                                  Number of dimensions    =     2 
Restricted log likelihood = -5.8048477         Number of observations  =    13 
 
 Coef. Std. Err. z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int  .250  .095  2.61  0.009  .062  .438 
1-6m   .030  .281  0.11  0.914 -.520  .581 
 
  
Table 9. Comparison of MBPs with passive control groups: multivariate meta-analysis of cognitive functioning 
at post-intervention, (Post-int), and 1-6 months follow-up (1-6m). Results were robust to the outcome-specific 
correlation sensitivity analysis.  








 Multivariate meta-analysis 
Variance-covariance matrix = unstructured 
Method = reml                                  Number of dimensions    =     1 
Restricted log likelihood = -2.5910786         Number of observations  =     3 
 
 Coef. Std. Err. z P>|z| [95% Conf. 
Interval] 
 
Overall mean       




Table 10. Comparison of MBPs with active non-specific control groups: multivariate meta-analysis of cognitive 
functioning at post-intervention. 








Meta-analysis summary                     Number of studies =      7 
Random-effects model                      Heterogeneity: 
Method: REML                                          tau2 =  0.0178 
SE adjustment: Truncated Knapp-Hartung              I2 (%) =   30.97 
                                                        H2 =    1.45 
 
-------------------------------------------------------------------- 
            Study |    Effect Size    [95% Conf. Interval]  % Weight 
------------------+------------------------------------------------- 
       Isbel 2019 |         -0.297      -0.739       0.146     12.78 
     Lebares 2019 |          0.174      -0.477       0.824      6.87 
          Ma 2019 |          0.169      -0.153       0.491     19.64 
     MacCoon 2012 |          0.256      -0.266       0.779      9.91 
  Malinowski 2017 |         -0.772      -1.387      -0.158      7.58 
        Oken 2010 |         -0.007      -0.160       0.147     36.75 
       Smart 2017 |          0.000      -0.673       0.673      6.48 
------------------+------------------------------------------------- 
            theta |         -0.028      -0.292       0.236 
-------------------------------------------------------------------- 
95% prediction interval for theta: [-0.469, 0.413] 
 
Test of theta = 0: t(6) = -0.26                  Prob > |t| = 0.8017 
Test of homogeneity: Q = chi2(6) = 10.01           Prob > Q = 0.1241 
 
  
Table 11. Comparison of MBPs with active specific control groups: univariate meta-analysis of 
cognitive functioning at post-intervention. 









Variance-covariance matrix = proportional .2*I(3)+.8*J(3,3,1) 
Method = reml                                  Number of dimensions    =     3 
Restricted log likelihood = -18.124991         Number of observations  =    29 
 
 Coef. Std. Err. z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int .272 .078 3.49 0.000  .119 .425 
1-6m  .225 .091 2.47 0.013  .046 .404 





Table 12. Comparison of MBPs with passive control groups: multivariate meta-analysis of real-life functioning 
at post-intervention, (Post-int), 1-6 months follow-up (1-6m), and 6+ months follow-up (+6m). Exchangeable 
between-study variance-covariance matrices (0.8). 











Variance-covariance matrix = proportional .9*I(2)+.1*J(2,2,1) 
Method = reml                                  Number of dimensions    =     2 
Restricted log likelihood = -4.1010413         Number of observations  =     4 
 
 Coef. Std. Err. z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int .038 .404 0.10 0.924 -.753  .831 




Table 13. Comparison of MBPs with active non-specific control groups: multivariate meta-analysis of real-life 
functioning at post-intervention, (Post-int), and 1-6 months follow-up (1-6m). Exchangeable between-study 
variance-covariance matrices (0.1). 










Variance-covariance matrix = proportional .1*I(3)+.9*J(3,3,1) 
Method = reml                                  Number of dimensions    =     3 
Restricted log likelihood = .19744653          Number of observations  =     9 
 
 Coef. Std. Err. z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int .030 .100 0.30 0.764 -.166 .227 
1-6m  .008 .113 0.08 0.939 -.214 .231 
+6m .024 .103 0.23 0.815 -.177 .226 
 
  
Table 14. Comparison of MBPs with active specific control groups: multivariate meta-analysis of real-life 
functioning at post-intervention, (Post-int), 1-6 months follow-up (1-6m), and 6+ months follow-up (+6m). 
Exchangeable between-study variance-covariance matrices (0.9). 









Variance-covariance matrix = unstructured 
Method = reml                                  Number of dimensions    =     2 
Restricted log likelihood = -20.512327         Number of observations  =    21 
 
 Coef. Std. Err. z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int .765 .153 5.00 0.000 .465 1.065 




Table 15. Comparison of MBPs with passive control groups: multivariate meta-analysis of relationship with the 
self at post-intervention, (Post-int), and 1-6 months follow-up (1-6m). 










Variance-covariance matrix = proportional .2*I(2)+.8*J(2,2,1) 
Method = reml                                  Number of dimensions    =     2 
Restricted log likelihood = -3.6406978         Number of observations  =     4 
 
 Coef. Std. Err. z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int .801 .277 2.89 0.004 .258 1.344 




Table 16. Comparison of MBPs with active non-specific control groups: multivariate meta-analysis of 
relationship with the self at post-intervention, (Post-int), and 1-6 months follow-up (1-6m). Exchangeable 
between-study variance-covariance matrices (0.8). 











Variance-covariance matrix = proportional .5*I(3)+.5*J(3,3,1) 
Method = reml                                  Number of dimensions    =     3 
Restricted log likelihood = -2.503334          Number of observations  =     7 
 
 Coef. Std. Err. z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int  .129 .143 0.90 0.366 -.151 .411 
1-6m   .398 .265 1.50 0.134 -.122 .919 
+6m 0.00 .460 0.00 1.000 -.902 .902 
 
  
Table 17. Comparison of MBPs with active specific control groups: multivariate meta-analysis of relationship 
with the self at post-intervention, (Post-int), 1-6 months follow-up (1-6m), and 6+ months follow-up (+6m). 
Exchangeable between-study variance-covariance matrices (0.5). 
 









Meta-analysis summary                     Number of studies =     14 
Random-effects model                      Heterogeneity: 
Method: REML                                          tau2 =  0.0522 
SE adjustment: Truncated Knapp-Hartung              I2 (%) =   61.93 
                                                        H2 =    2.63 
 
-------------------------------------------------------------------- 
            Study |    Effect Size    [95% Conf. Interval]  % Weight 
------------------+------------------------------------------------- 
     Barrett 2012 |         -0.127      -0.476       0.223      7.59 
     Barrett 2018 |         -0.014      -0.250       0.221      9.56 
     Carmody 2011 |         -0.301      -0.700       0.098      6.81 
 Christopher 2018 |         -0.464      -0.861      -0.067      6.84 
   Dvorakova 2017 |         -0.361      -0.683      -0.038      8.04 
     Greeson 2014 |         -0.529      -0.888      -0.171      7.44 
       Hwang 2019 |         -0.369      -0.708      -0.030      7.76 
       Klatt 2009 |         -0.198      -0.652       0.255      6.02 
       Klatt 2017 |         -0.621      -1.062      -0.180      6.19 
         Lee 2010 |         -0.783      -1.194      -0.372      6.62 
    Moynihan 2013 |         -0.142      -0.363       0.080      9.81 
        Oken 2010 |         -0.450      -1.188       0.287      3.29 
        Park 2016 |         -0.647      -1.044      -0.250      6.84 
      Wilson 2012 |         -1.022      -1.396      -0.648      7.19 
------------------+------------------------------------------------- 
            theta |         -0.409      -0.581      -0.236 
-------------------------------------------------------------------- 
95% prediction interval for theta: [-0.936, 0.119] 
 
Test of theta = 0: t(13) = -5.12                 Prob > |t| = 0.0002 





Table 18. Comparison of MBPs with passive control groups: univariate meta-analysis of 
psychosomatic symptoms at post-intervention. 








Meta-analysis summary                     Number of studies =      7 
Random-effects model                      Heterogeneity: 
Method: REML                                          tau2 =  0.1332 
SE adjustment: Truncated Knapp-Hartung              I2 (%) =   79.31 
                                                        H2 =    4.83 
 
-------------------------------------------------------------------- 
            Study |    Effect Size    [95% Conf. Interval]  % Weight 
------------------+------------------------------------------------- 
     Barrett 2012 |         -0.026      -0.414       0.363     14.53 
     Barrett 2018 |         -0.010      -0.246       0.226     16.96 
     Carmody 2011 |         -0.233      -0.674       0.207     13.64 
 Christopher 2018 |         -0.223      -0.785       0.339     11.63 
       Hwang 2019 |         -0.293      -0.693       0.107     14.33 
    Moynihan 2013 |          0.098      -0.180       0.375     16.35 
      Wilson 2012 |         -1.239      -1.742      -0.735     12.57 
------------------+------------------------------------------------- 
            theta |         -0.245      -0.645       0.155 
-------------------------------------------------------------------- 
95% prediction interval for theta: [-1.273, 0.783] 
 
Test of theta = 0: t(6) = -1.50                  Prob > |t| = 0.1846 





Table 19. Comparison of MBPs with passive control groups: univariate meta-analysis of psychosomatic 
symptoms at 1-6 months follow-up. 










Variance-covariance matrix = proportional .5*I(2)+.5*J(2,2,1) 
Method = reml                                  Number of dimensions    =     2 
Restricted log likelihood = -.11828547         Number of observations  =     2 
 
 Coef. Std. Err. z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int -.358 .195 -1.83 0.067 -.742 .024 




Table 20. Comparison of MBPs with active non-specific control groups: multivariate meta-analysis of 
psychosomatic symptoms at post-intervention, (Post-int), and 1-6 months follow-up (1-6m). Exchangeable 
between-study variance-covariance matrices (0.5). 









Variance-covariance matrix = proportional .2*I(3)+.8*J(3,3,1) 
Method = reml                                  Number of dimensions    =     3 
Restricted log likelihood = -1.3820193         Number of observations  =     7 
 
 Coef. Std. Err. z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int -.181 .099 -1.82 0.068 -.376 .013 
1-6m  -.133 .116 -1.15 0.250 -.360 .093 
+6m -.146 .139 -1.05 0.292 -.420 .126 
 
  
Table 21. Comparison of MBPs with active specific control groups: multivariate meta-analysis of psychosomatic 
symptoms at post-intervention, (post-int), 1-6 months follow-up (1-6m), and 6+ months follow-up (+6m). 
Exchangeable between-study variance-covariance matrices (0.8). 









Variance-covariance matrix = proportional .1*I(3)+.9*J(3,3,1) 
Method = reml                                  Number of dimensions    =     3 
Restricted log likelihood = -40.775514         Number of observations  =    52 
 
 Coef. Std. Err. z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int .538 .068 7.91 0.000 .405 .672 
1-6m  .559 .080 6.95 0.000 .401 .716 




Table 22. Comparison of MBPs with passive control groups: multivariate meta-analysis of dispositional 
mindfulness at post-intervention, (post-int), 1-6 months follow-up (1-6m), and 6+ months follow-up (+6m). 
Exchangeable between-study variance-covariance matrices (0.9). 









Variance-covariance matrix = unstructured 
Method = reml                                  Number of dimensions    =     2 
Restricted log likelihood = -4.2903167         Number of observations  =     8 
 
 Coef. Std. Err. z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int .212 .116 1.83 0.068 -.015 .440 
1-6m  .274 .171 1.60 0.110 -.062 .611 
 
  
Table 23. Comparison of MBPs with active non-specific control groups: multivariate meta-analysis of 
dispositional mindfulness at post-intervention, (post-int), and 1-6 months follow-up (1-6m). 










Variance-covariance matrix = proportional .1*I(3)+.9*J(3,3,1) 
Method = reml                                  Number of dimensions    =     3 
Restricted log likelihood = -7.8690442         Number of observations  =    19 
 
 Coef. Std. Err. z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int .135 .080 1.67 0.094 -.023 .293 
1-6m  .122 .096 1.27 0.204 -.066 .312 
+6m .153 .123 1.25 0.212 -.087 .395 
 
  
Table 24. Comparison of MBPs with active specific control groups: multivariate meta-analysis of dispositional 
mindfulness at post-intervention, (post-int), 1-6 months follow-up (1-6m), and 6+ months follow-up (+6m). 
Exchangeable between-study variance-covariance matrices (0.9). 
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Table 25. Risk of bias assessment for individual studies. 
Study D1 D2 D3 D4 D5 
Aeamla-Or 2015 Low Low Low High Some 
Agee 2009 Some High High High High 
Allen 2012 Some High High Some Some 
Amutio 2015 Some High High High Some 
Anclair 2018 Some High Some High Some 
Anderson 2007 Some High High Some for test, high for self-report Some 
Armstrong 2016 Low Some High High Some 
Arredondo 2017 Some High High High Some 
Astin 1997 Some High High High Some 
Asuero 2014 Some High High High Some 
Auseron 2018 Low Some High High High 
Barrett 2012 Low High Low High Some 
Barrett 2018 Low Some Low High Low 
Beattie 2017 Low Some High High Low 
Behbahani 2018 Some High High High Some 
Benn 2012 Some High High High Some 
Berghmans 2010 Some High High High Some 
Black 2015 Low Some Some High Some 
Brown 2016 Some Some Low High Some 
Carmody 2011 Low High High High Some 
Carson 2004* Some for D1, Low for D2 high high high some 
Cerna 2019 Low High High High Some 
Christopher 2018 Some High Some High Some 
Cohen-Katz 2004 Some High High High Some 
Corsica 2014 Some High High High Some 
Cousin 2016 Some High High High Some 
DamiãoNeto 2019 Some Some High High Some 
Davidson 2003 Some High High High Some 
Delgado 2010 Some High High High Some 
Delgado-Pastor 2015 Some High High High Some 
Desbordes 2012 Some High High High Some 
DeVibe 2013 Low High High High Some 
Duncan 2017 Low Low Low Low for test, high for self-report Some 
Dvorakova 2017 Some High Low High Some 
Dykens 2014 Some High Some High High 
Dziok 2010 Some High High High Some 
Esch 2017 Low High Low Low for test, high for self-report Some 
Ferraioli 2013 Some High High High Some 
Fiocco 2018 Some Some High High Some 
Flook 2013 Some High High High Some 
Frisvold 2009 Some Some Low High Some 
Galante 2018 Low Some Low Low for test, high for self-report Low 
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Gallego 2014 Some High High High Some 
Gambrel 2015* Some for D1, Low for D2 high high high some 
Giannandrea 2018 Some High High High Some 
Glass 2019 Some High High High Some 
Grandpierre 2013 Some High High High Some 
Greenberg 2010 Some High High Some Some 
Greeson 2014 Some High Some High Some 
Guardino 2014 Some Some High High Some 
Haarig 2016 Some High Low High Some 
Hou 2013 Low High High High Some 
Huang 2015 Low High Low High Some 
Hunt 2018 Some High High High Some 
Hwang 2019* Low for D1, Some for D2 some some high some 
Ireland 2017 Some High Some High Some 
Isbel 2019 Some High High Some for test, high for self-report Some 
Jain 2007 Some High High High Some 
James 2018 Low Some High High Some 
Josefsson 2014 Some High High Some for test, high for self-report Some 
Kang 2009 Low High High High Some 
Kaviani 2008 Some High Low High Some 
Kingston 2007 Low Some High High Some 
Kirk 2016 Some High High High Some 
Klatt 2009 Some High High High Some 
Klatt 2017 Some High Some High Some 
Kor 2019 Low Some Low High Low 
Krick 2019 Some Some Low High Some 
Kuhlmann 2016 Low High High High Low 
Lacerda 2018 Some High High High Some 
Lara-Cinisomo 2019 Some High Low High Some 
Lebares 2019 Some High Low Low for test, high for self-report Some 
Lee 2010 Some High High High Some 
Li 2018 Some High High High Some 
Lin 2019 Some High High High Some 
Liu 2013 Some High High High Some 
Liu 2015 Some High High High Some 
Lo 2017 Some High Low High Some 
Lonnberg 2020 Low Some Low High Some 
Lopez-Maya 2019 Low Some Some High Some 
Lynch 2018 Some High High High Some 
Ma 2019 Some Some Low Low for test, high for self-report Some 
MacCoon 2012 Low Some Some Low for test, high for self-report High 
Malarkey 2013 Some Some High High Some 
Malinowski 2017 Some Some High Some for test, high for self-report Some 
Manotas 2014 Some High High High Some 
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Moody 2013 Some High High High Some 
Moritz 2006 Low High High High Some 
Moynihan 2013* High for D1, Low for D2 high some high some 
Mrazek 2013 Some High High High Some 
Neece 2014* Low for D1, Low for D2 high some high some 
Norouzi 2020 Some Some Low High Some 
Nyklicek 2008 Some High High High Some 
ODonnell 2017 Some High Some High Some 
Oken 2010 Some High High Low for test, high for self-report Some 
Pan 2018 Low High Low High Some 
Park 2016 Some High High High Some 
Perez-Blasco 2013 Some High Some High Some 
Perez-Blasco 2016 Some High Low High Some 
Phang 2015 Low High Low High Some 
Pipe 2009 Some Some Low High Some 
Plummer 2018 Some High High High Some 
Pots 2014 Low High Low High Some 
Prakash 2015 Some Some Low Low for test, high for self-report Some 
Richards 2012 Some High High High Some 
Richards 2013 Some High Some High Some 
Robins 2012 Some High High High Some 
Roeser 2013 Some High High Some for test, high for self-report Some 
Sampl 2017 Some High High Low for test, high for self-report Some 
Schellekens 2017 Low High Low High Low 
Schroeder 2018 Some High High Low for test, high for self-report Some 
Sevinc 2018* Low for D1, Low for D2 some low high some 
Shapiro 1998 Some High High High Some 
Shapiro 2005 Some High High High Some 
Shapiro 2019 Some High High High Some 
Shearer 2016 Some High High High Some 
Smart 2017 Some High High High Some 
Ștefan 2018 Some High High High Some 
Steinberg 2016 Some High Low High Some 
Strub 2013 Some High Low High Some 
Thomas 2016 Some High Some High Some 
VanBerkel 2014 Some High Some Low for test, high for self-report Some 
VanDam 2014 Some High High High Some 
vanDijk 2017* Low for D1, Low for D2 some low high some 
Verweij 2018 Some High Low High Some 
Vieten 2008 Some High Low High Some 
Vinesett 2017 Some Some High High Some 
Wang 2012 Some High Low High Some 
Whitebird 2013 Some High Low High Some 
Williams 2001 Some High High High Some 
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Wilson 2012 Some High High High Some 
Wong 2018 Low Some Some High Some 
Woolhouse 2014 Low High Some High Some 
Xu 2015 Some High High High Some 
Yazdanimehr 2016 Some High High High Some 
Zhang 2018 Some High High High Some 
The RoB2 tool measures potential bias across five sources (called ‘domains’ in the tool): (D1) randomisation, (D2) 
deviations from intended interventions, (D3) missing outcome data, (D4) measurement of the outcome, and (D5) 
selection of the reported result. * Cluster RCTs, which were assessed with their specific sub-set of questions [58]. 
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MBSR Improves Memory and Attention 
Due to a Stress Reduction as Opposed to 
Specific Memory Training 
NCT02672761 140 Passive 
& active 
Unlikely 
Effects of Mindfulness Training on Emotion 
Regulation and Social Cognition, a 
Psychophysiological and Neuroimaging 
Randomized Controlled Study. 
NCT03035669 60 Active Unlikely 
The Mindfulness Intervention and 
Repeated Acute Stress (MIRAS) Study 
NCT02894229 150 Passive 
& active 
Unlikely 
Promoting Mental Well-being of Pregnant 
Women with Mindfulness-Based Childbirth 
and Parenting (MBCP) in Hong Kong 
ChiCTR-TRC-
13004070 
178 Active Time point not 
specified 
Mindfulness-based Training in the 
Workplace - evaluating the cost 
effectiveness and impact on emotional 
wellbeing 
ISRCTN03386834 60 Passive Likely 
The Effects of Well-being Interventions on 
Affect, Attention, Sleep, Social Stress and 
Pain Regulation 
NCT01057368 161 Passive 
& active 
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Table 27. Grading of Recommendations Assessment, Development and Evaluation (GRADE) assessment details by 

























































NC Distress 1-6m Serious Serious Serious Serious Not 
serious 
Very low 




Serious Serious Very Low 
AC Anxiety 1-6m Serious Not 
serious 
Serious Serious Not 
serious 
Very low 







AC Distress 1-6m Serious Serious Serious Serious Not 
serious 
Very low 
AC Wellbeing 1-6m Serious Serious Serious Serious Not 
serious 
Very low 
Abbreviations:  RoB=Risk of bias, 1-6m= 1 to 6 months post-intervention, non-rep: non-reporting, PC=passive controls, 
NC=active non-specific controls, AC=active specific controls. 
 
  










Variance-covariance matrix = proportional .9*I(11)+.1*J(11,11,1) 
Method = reml                                  Number of dimensions    =    11 
Restricted log likelihood = -52.49954          Number of observations  =    29 
 
 Coef. Std. 
Err. 
z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int anxiety -.589 .114 -5.15 0.000 -.813 -.364 
1-6m anxiety -.218 .179 -1.22 0.224 -.569  .133 
Post-int depression -.267 .086 -3.10 0.002 -.436 -.097 
1-6m depression -.244 .126 -1.93 0.054 -.492  .003 
+6m depression -.144 .272 -0.53 0.596 -.677  .389 
Post-int distress -.381 .069 -5.49 0.000 -.518 -.245 
1-6m distress -.295 .092 -3.19 0.001 -.476 -.114 
+6m distress -.178 .162 -1.10 0.271 -.496  .139  
Post-int wellbeing  .354 .102  3.48 0.001  .154  .554 
1-6m wellbeing  .269 .143   2.07 0.038  .015  .577 






Table 28. Sensitivity analysis of methodological quality removing high-risk-of-bias trials. Comparison of MBPs 
with passive control groups: multivariate meta-analysis of anxiety, depression, distress, and wellbeing at post-
intervention, (post-int), 1-6 months follow-up, (1-6m) and 6+ months follow-up (+6m). 











Variance-covariance matrix = proportional .3*I(8)+.7*J(8,8,1) 
Method = reml                                  Number of dimensions    =     8 
Restricted log likelihood = -22.551656         Number of observations  =    10 
 
 Coef. Std. 
Err. 
z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int anxiety -.675 .266 -2.54 0.011 -1.197 -.153 
1-6m anxiety -.553 .262 -2.11 0.035 -1.068 -.038 
Post-int depression -.435 .216 -2.01 0.044 -.860 -.010 
1-6m depression -.463 .224 -2.07 0.039 -.904 -.023 
Post-int distress -.398 .199 -2.00 0.046 -.790 -.007 
1-6m distress -.096 .233 -0.41 0.680 -.555  .361 
Post-int wellbeing  3.278 .705  4.65 0.000  1.897 4.660 




Table 29. Sensitivity analysis of methodological quality removing high-risk-of-bias trials. Comparison of MBPs 
with active non-specific control groups: multivariate meta-analysis of anxiety, depression, distress, and 
wellbeing at post-intervention, (post-int), 1-6 months follow-up, (1-6m) and 6+ months follow-up (+6m). 










Variance-covariance matrix = proportional .9*I(11)+.1*J(11,11,1) 
Method = reml                                  Number of dimensions    =    11 
Restricted log likelihood = -14.333741         Number of observations  =    17 
 
 Coef. Std. 
Err. 
z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int anxiety  -.066   .154   -0.43   0.666   -.370    .236 
1-6m anxiety   .377   .206    1.83   0.068   -.027    .782 
Post-int depression  -.303   .076   -3.95   0.000   -.453   -.153 
1-6m depression  -.212   .087   -2.44   0.015   -.382   -.041 
+6m depression  -.032   .146   -0.22   0.826   -.319    .255 
Post-int distress  -.168   .068   -2.47   0.014   -.302   -.034 
1-6m distress  -.048   .085   -0.56   0.573   -.216    .119 
+6m distress   .045   .144    0.32   0.751   -.237    .329 
Post-int wellbeing   .086   .105    0.82   0.411   -.120    .293 
1-6m wellbeing   .032   .128    0.25   0.799   -.219    .285 
+6m wellbeing  -.011   .185   -0.06   0.949   -.376    .352 
 
  
Table 30. Sensitivity analysis of methodological quality removing high-risk-of-bias trials. Comparison of MBPs with 
active specific control groups: multivariate meta-analysis of anxiety, depression, distress, and wellbeing at post-
intervention, (post-int), 1-6 months follow-up, (1-6m) and 6+ months follow-up (+6m). 










Variance-covariance matrix = proportional .9*I(11)+.1*J(11,11,1) 
Method = reml                                  Number of dimensions    =    11 
Restricted log likelihood = -3.302925          Number of observations  =     8 
 
 Coef. Std. 
Err. 
z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int anxiety -.403 .184 -2.19 0.029 -.765 -.042 
1-6m anxiety  .089 .134  0.67 0.506 -.174  .352 
Post-int depression -.262 .110 -2.37 0.018 -.479 -.045 
1-6m depression -.310 .112 -2.77 0.006 -.529 -.090 
+6m depression -.222 .161 -1.37 0.170 -.539  .095 
Post-int distress -.407 .068 -5.96 0.000 -.541 -.273 
1-6m distress -.394 .081 -4.81 0.000 -.554 -.233 
+6m distress -.213 .102 -2.09 0.036 -.414 -.013 
Post-int wellbeing  .227 .101  2.25 0.025  .029  .426 
1-6m wellbeing  .317 .100  3.15 0.002  .119  .515 




Table 31. Sensitivity analysis of methodological quality removing trials at high risk of bias due to deviations 
from intended interventions. Comparison of MBPs with passive control groups: multivariate meta-analysis of 
anxiety, depression, distress, and wellbeing at post-intervention, (post-int), 1-6 months follow-up, (1-6m) and 6+ 
months follow-up (+6m). 










Variance-covariance matrix = proportional .9*I(11)+.1*J(11,11,1) 
Method = reml                                  Number of dimensions    =    11 
Restricted log likelihood = -141.86393         Number of observations  =    78 
 
 Coef. Std. 
Err. 
z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int anxiety -.708 .101 -6.96 0.000 -.907 -.508 
1-6m anxiety -.685 .150 -4.55 0.000 -.981 -.390 
Post-int depression -.465 .074 -6.18 0.000 -.610 -.320 
1-6m depression -.580 .117 -4.96 0.000 -.810 -.351 
+6m depression -.089 .371 -0.24 0.810 -.816  .638 
Post-int distress -.447 .055 -8.10 0.000 -.555 -.338 
1-6m distress -.454 .081 -5.56 0.000 -.614 -.294 
+6m distress -.125 .195 -0.64 0.522 -.509  .258 
Post-int wellbeing  .366 .083  4.39 0.000  .203  .530 
1-6m wellbeing  .268 .133  2.00 0.045  .005  .530 




Table 32. Sensitivity analysis of within-study correlation assumptions using Riley’s method. Comparison of 
MBPs with passive control groups: multivariate meta-analysis of anxiety, depression, distress, and wellbeing at 
post-intervention, (post-int), 1-6 months follow-up, (1-6m) and 6+ months follow-up (+6m). 









Variance-covariance matrix = proportional .3*I(8)+.7*J(8,8,1) 
Method = reml                                  Number of dimensions    =     8 
Restricted log likelihood = -24.812373         Number of observations  =    11 
 
 Coef. Std. 
Err. 
z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int anxiety -.587 .222 -2.64 0.008 -1.023 -.151 
1-6m anxiety -.422 .217 -1.94 0.053 -.849  .004 
Post-int depression -.445 .191 -2.33 0.020 -.820 -.071 
1-6m depression -.436 .192 -2.27 0.023 -.813 -.059 
Post-int distress -.390 .177 -2.20 0.028 -.739 -.042 
1-6m distress -.111 .200 -0.56 0.578 -.504  .281 
Post-int wellbeing 4.824 .429 11.24 0.000  3.983 5.666 




Table 33. Sensitivity analysis of within-study correlation assumptions using Riley’s method. Comparison of 
MBPs with active non-specific control groups: multivariate meta-analysis of anxiety, depression, distress, and 
wellbeing at post-intervention, (post-int), 1-6 months follow-up, (1-6m) and 6+ months follow-up (+6m). 
 











Variance-covariance matrix = proportional .9*I(11)+.1*J(11,11,1) 
Method = reml                                  Number of dimensions    =    11 
Restricted log likelihood = -18.786589         Number of observations  =    31 
 
 Coef. Std. 
Err. 
z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int anxiety  -.133   .090   -1.48   0.139   -.310    .043 
1-6m anxiety  -.020   .181   -0.11   0.909   -.377    .335 
Post-int depression  -.289   .060   -4.75   0.000   -.408   -.169 
1-6m depression  -.210   .078   -2.70   0.007   -.364   -.057 
+6m depression  -.042   .145   -0.29   0.771   -.327    .242 
Post-int distress  -.092  .051   -1.79   0.073   -.193    .008 
1-6m distress  -.056  .072   -0.78   0.434   -.198    .085 
+6m distress  -.093   .126   -0.74   0.462   -.340    .154 
Post-int wellbeing  .110   .070    1.57   0.116   -.027    .249 
1-6m wellbeing  -.021   .113   -0.19   0.850   -.243    .200 
+6m wellbeing  -.028   .165   -0.17   0.864   -.351    .295 
  
Table 34. Sensitivity analysis of within-study correlation assumptions using Riley’s method. Comparison of 
MBPs with active specific control groups: multivariate meta-analysis of anxiety, depression, distress, and 
wellbeing at post-intervention, (post-int), 1-6 months follow-up, (1-6m) and 6+ months follow-up (+6m). 







Meta-analysis summary                     Number of studies =      8 
Random-effects model                      Heterogeneity: 
Method: REML                                          tau2 =  0.5671 
SE adjustment: Truncated Knapp-Hartung              I2 (%) =   95.11 
                                                        H2 =   20.47 
 
-------------------------------------------------------------------- 
            Study |    Effect Size    [95% Conf. Interval]  % Weight 
------------------+------------------------------------------------- 
     Carmody 2011 |         -0.487      -0.789      -0.184     13.35 
 Christopher 2018 |          0.190      -0.262       0.642     12.72 
       Dziok 2010 |         -1.008      -1.682      -0.335     11.51 
     Kaviani 2008 |         -2.427      -3.286      -1.567     10.39 
         Kor 2019 |          0.020      -0.092       0.132     13.83 
       Sampl 2017 |         -0.827      -1.117      -0.537     13.39 
      VanDam 2014 |         -1.153      -1.700      -0.607     12.23 
 Yazdanimehr 2016 |         -1.474      -1.952      -0.997     12.59 
------------------+------------------------------------------------- 
            theta |         -0.844      -1.525      -0.162 
-------------------------------------------------------------------- 
95% prediction interval for theta: [-2.817, 1.129] 
 
Test of theta = 0: t(7) = -2.93                  Prob > |t| = 0.0221 






Meta-analysis summary                     Number of studies =     14 
Random-effects model                      Heterogeneity: 
Method: REML                                          tau2 =  0.6351 
SE adjustment: Truncated Knapp-Hartung              I2 (%) =   93.22 
                                                        H2 =   14.76 
 
-------------------------------------------------------------------- 
            Study |    Effect Size    [95% Conf. Interval]  % Weight 
------------------+------------------------------------------------- 
   Aeamla-Or 2015 |         -0.334      -0.639      -0.028      7.69 
     Barrett 2018 |         -0.015      -0.251       0.221      7.80 
        Benn 2012 |         -0.302      -0.814       0.210      7.21 
     Carmody 2011 |         -0.296      -0.672       0.080      7.54 
 Christopher 2018 |          0.296      -0.167       0.760      7.34 
       Dziok 2010 |         -0.949      -1.890      -0.008      5.86 
      Haarig 2016 |         -0.843      -1.473      -0.212      6.86 
     Kaviani 2008 |         -1.984      -2.794      -1.174      6.29 
         Kor 2019 |         -0.571      -1.040      -0.102      7.32 
    Moynihan 2013 |          0.000      -0.277       0.277      7.74 
      Roeser 2013 |         -1.118      -1.530      -0.707      7.46 
      VanDam 2014 |         -1.258      -1.679      -0.838      7.44 
      Vieten 2008 |          0.566      -0.163       1.295      6.55 
 Yazdanimehr 2016 |         -2.604      -3.226      -1.982      6.89 
------------------+------------------------------------------------- 
            theta |         -0.649      -1.143      -0.155 
-------------------------------------------------------------------- 
95% prediction interval for theta: [-2.455, 1.158] 
 
Test of theta = 0: t(13) = -2.84                 Prob > |t| = 0.0140 
Test of homogeneity: Q = chi2(13) = 128.63         Prob > Q = 0.0000 
Table 35. Sensitivity analysis of within study correlation assumptions. Univariate meta-analyses of anxiety, 
depression, distress and wellbeing outcomes comparing MBPs with passive control groups. 







Meta-analysis summary                     Number of studies =     27 
Random-effects model                      Heterogeneity: 
Method: REML                                          tau2 =  0.0745 
SE adjustment: Truncated Knapp-Hartung              I2 (%) =   66.97 
                                                        H2 =    3.03 
 
-------------------------------------------------------------------- 
            Study |    Effect Size    [95% Conf. Interval]  % Weight 
------------------+------------------------------------------------- 
   Aeamla-Or 2015 |         -0.337      -0.660      -0.015      4.55 
   Arredondo 2017 |         -1.474      -2.254      -0.693      1.98 
     Barrett 2012 |         -0.106      -0.476       0.265      4.19 
     Barrett 2018 |         -0.021      -0.257       0.215      5.20 
   Behbahani 2018 |         -0.713      -1.233      -0.192      3.19 
        Benn 2012 |         -0.672      -1.241      -0.102      2.91 
     Carmody 2011 |         -0.512      -0.848      -0.175      4.45 
      Carson 2004 |         -0.741      -1.147      -0.336      3.94 
 Christopher 2018 |         -0.085      -0.597       0.427      3.24 
    Davidson 2003 |          0.000      -0.627       0.627      2.61 
     Galante 2018 |         -0.419      -0.581      -0.257      5.68 
       Huang 2015 |         -0.449      -0.755      -0.143      4.67 
       Hwang 2019 |         -0.454      -0.830      -0.078      4.15 
         Kor 2019 |         -0.838      -1.438      -0.238      2.75 
         Lin 2019 |         -0.557      -0.950      -0.165      4.04 
      Moritz 2006 |         -0.385      -0.738      -0.033      4.33 
    Moynihan 2013 |          0.000      -0.277       0.277      4.89 
       Phang 2015 |         -0.247      -0.674       0.180      3.79 
     Plummer 2018 |         -0.397      -0.756      -0.038      4.28 
       Sampl 2017 |         -0.860      -1.213      -0.507      4.32 
 Schellekens 2017 |          0.197      -0.451       0.844      2.52 
   Schroeder 2018 |         -0.922      -1.648      -0.197      2.19 
      VanDam 2014 |         -0.613      -1.291       0.065      2.38 
      Vieten 2008 |          0.580      -0.150       1.309      2.17 
      Wilson 2012 |         -1.022      -1.468      -0.577      3.67 
 Yazdanimehr 2016 |         -1.040      -1.502      -0.578      3.55 
     vanDijk 2017 |         -0.412      -0.760      -0.064      4.36 
------------------+------------------------------------------------- 
            theta |         -0.446      -0.597      -0.295 
-------------------------------------------------------------------- 
95% prediction interval for theta: [-1.028, 0.136] 
 
Test of theta = 0: t(26) = -6.08                 Prob > |t| = 0.0000 









Meta-analysis summary                     Number of studies =      9 
Random-effects model                      Heterogeneity: 
Method: REML                                          tau2 =  0.0267 
SE adjustment: Truncated Knapp-Hartung              I2 (%) =   53.18 
                                                        H2 =    2.14 
 
-------------------------------------------------------------------- 
            Study |    Effect Size    [95% Conf. Interval]  % Weight 
------------------+------------------------------------------------- 
     Barrett 2012 |          0.190      -0.163       0.543     10.59 
     Barrett 2018 |          0.019      -0.217       0.254     15.20 
        Benn 2012 |          0.319      -0.228       0.865      5.99 
    Davidson 2003 |          0.000      -0.627       0.627      4.84 
     Galante 2018 |          0.286       0.130       0.443     18.94 
         Lin 2019 |          0.655       0.267       1.042      9.52 
    Moynihan 2013 |          0.079      -0.167       0.325     14.75 
      Wilson 2012 |          0.592       0.171       1.014      8.57 
     vanDijk 2017 |          0.512       0.189       0.835     11.60 
------------------+------------------------------------------------- 
            theta |          0.280       0.098       0.463 
-------------------------------------------------------------------- 
95% prediction interval for theta: [-0.149, 0.710] 
 
Test of theta = 0: t(8) = 3.55                   Prob > |t| = 0.0076 













Meta-analysis summary                     Number of studies =      4 
Random-effects model                      Heterogeneity: 
Method: REML                                          tau2 =  0.6123 
SE adjustment: Truncated Knapp-Hartung              I2 (%) =   93.16 
                                                        H2 =   14.61 
 
-------------------------------------------------------------------- 
            Study |    Effect Size    [95% Conf. Interval]  % Weight 
------------------+------------------------------------------------- 
   Armstrong 2016 |         -0.336      -0.889       0.217     23.99 
         Hou 2013 |         -0.257      -0.575       0.060     25.99 
       James 2018 |         -0.156      -0.509       0.197     25.74 
     Norouzi 2020 |         -1.900      -2.424      -1.377     24.28 
------------------+------------------------------------------------- 
            theta |         -0.649      -1.956       0.658 
-------------------------------------------------------------------- 
95% prediction interval for theta: [-4.452, 3.154] 
 
Test of theta = 0: t(3) = -1.58                  Prob > |t| = 0.2122 






Meta-analysis summary                     Number of studies =      6 
Random-effects model                      Heterogeneity: 
Method: REML                                          tau2 =  0.3364 
SE adjustment: Truncated Knapp-Hartung              I2 (%) =   90.31 
                                                        H2 =   10.32 
 
-------------------------------------------------------------------- 
            Study |    Effect Size    [95% Conf. Interval]  % Weight 
------------------+------------------------------------------------- 
   Armstrong 2016 |         -0.011      -0.538       0.516     15.72 
      Duncan 2017 |         -0.804      -1.434      -0.174     14.61 
    Frisvold 2009 |         -0.508      -0.702      -0.314     18.56 
         Hou 2013 |         -0.418      -0.764      -0.073     17.49 
       James 2018 |         -0.125      -0.538       0.287     16.88 
     Norouzi 2020 |         -1.738      -2.164      -1.311     16.74 
------------------+------------------------------------------------- 
            theta |         -0.599      -1.252       0.054 
-------------------------------------------------------------------- 
95% prediction interval for theta: [-2.357, 1.159] 
 
Test of theta = 0: t(5) = -2.36                  Prob > |t| = 0.0650 





Table 36. Sensitivity analysis of within study correlation assumptions. Univariate meta-analyses of anxiety, 
depression, distress and wellbeing outcomes compared with active non-specific control groups. 





Meta-analysis summary                     Number of studies =      6 
Random-effects model                      Heterogeneity: 
Method: REML                                          tau2 =  0.0000 
SE adjustment: Truncated Knapp-Hartung              I2 (%) =    0.00 
                                                        H2 =    1.00 
 
-------------------------------------------------------------------- 
            Study |    Effect Size    [95% Conf. Interval]  % Weight 
------------------+------------------------------------------------- 
       Brown 2016 |         -0.058      -0.670       0.553     10.75 
    Frisvold 2009 |          0.003      -0.579       0.584     11.88 
    Guardino 2014 |         -0.306      -0.958       0.346      9.44 
         Hou 2013 |         -0.241      -0.567       0.084     37.92 
       James 2018 |         -0.322      -0.795       0.152     17.94 
     Norouzi 2020 |         -0.724      -1.301      -0.148     12.07 
------------------+------------------------------------------------- 
            theta |         -0.271      -0.534      -0.009 
-------------------------------------------------------------------- 
95% prediction interval for theta: [-0.555, 0.012] 
 
Test of theta = 0: t(5) = -2.66                  Prob > |t| = 0.0452 
Test of homogeneity: Q = chi2(5) = 3.78            Prob > Q = 0.5820 
 
 
Wellbeing: only one study available. 
 
  









Meta-analysis summary                     Number of studies =      2 
Random-effects model                      Heterogeneity: 
Method: REML                                          tau2 =  0.0000 
SE adjustment: Truncated Knapp-Hartung              I2 (%) =    0.00 
                                                        H2 =    1.00 
 
-------------------------------------------------------------------- 
            Study |    Effect Size    [95% Conf. Interval]  % Weight 
------------------+------------------------------------------------- 
      Dykens 2014 |         -0.185      -0.598       0.227     60.92 
          Ma 2019 |          0.127      -0.388       0.642     39.08 
------------------+------------------------------------------------- 
            theta |         -0.063      -2.152       2.026 
-------------------------------------------------------------------- 
95% prediction interval for theta: [     .,     .] 
 
Test of theta = 0: t(1) = -0.39                  Prob > |t| = 0.7660 





Meta-analysis summary                     Number of studies =      9 
Random-effects model                      Heterogeneity: 
Method: REML                                          tau2 =  0.0336 
SE adjustment: Truncated Knapp-Hartung              I2 (%) =   61.62 
                                                        H2 =    2.61 
 
-------------------------------------------------------------------- 
            Study |    Effect Size    [95% Conf. Interval]  % Weight 
------------------+------------------------------------------------- 
     Barrett 2018 |          0.002      -0.012       0.016     25.18 
     Beattie 2017 |         -0.025      -0.853       0.803      4.00 
      Dykens 2014 |         -0.035      -0.446       0.377     10.90 
    Lonnberg 2020 |         -0.179      -0.438       0.080     16.59 
          Ma 2019 |         -0.774      -1.319      -0.228      7.64 
    ODonnell 2017 |         -0.901      -1.751      -0.051      3.83 
         Pan 2018 |         -0.396      -0.684      -0.108     15.35 
    Vinesett 2017 |          0.265      -0.930       1.460      2.09 
   Whitebird 2013 |         -0.296      -0.607       0.016     14.41 
------------------+------------------------------------------------- 
            theta |         -0.225      -0.441      -0.010 
-------------------------------------------------------------------- 
95% prediction interval for theta: [-0.712, 0.261] 
 
Test of theta = 0: t(8) = -2.42                  Prob > |t| = 0.0421 
Test of homogeneity: Q = chi2(8) = 24.88           Prob > Q = 0.0016 
 
  
Table 37. Sensitivity analysis of within study correlation assumptions. Univariate meta-analyses of anxiety, 
depression, distress and wellbeing outcomes comparing MBPs with active specific control groups. 





Meta-analysis summary                     Number of studies =     11 
Random-effects model                      Heterogeneity: 
Method: REML                                          tau2 =  0.0092 
SE adjustment: Truncated Knapp-Hartung              I2 (%) =   90.55 
                                                        H2 =   10.58 
 
-------------------------------------------------------------------- 
            Study |    Effect Size    [95% Conf. Interval]  % Weight 
------------------+------------------------------------------------- 
     Barrett 2012 |          0.111       0.074       0.149     23.76 
     Barrett 2018 |         -0.000      -0.014       0.014     24.57 
     Beattie 2017 |          0.147      -0.787       1.081      0.96 
     Corsica 2014 |          0.000      -0.709       0.709      1.62 
      Dykens 2014 |         -0.013      -0.425       0.399      4.26 
    Lonnberg 2020 |         -0.064      -0.359       0.231      7.14 
          Ma 2019 |         -0.039      -0.590       0.512      2.58 
      Moritz 2006 |          0.117       0.083       0.150     23.97 
    Vinesett 2017 |          0.073      -1.114       1.261      0.61 
   Whitebird 2013 |         -0.445      -0.875      -0.014      3.96 
        Wong 2018 |         -0.269      -0.582       0.044      6.56 
------------------+------------------------------------------------- 
            theta |          0.015      -0.092       0.121 
-------------------------------------------------------------------- 
95% prediction interval for theta: [-0.228, 0.257] 
 
Test of theta = 0: t(10) = 0.31                  Prob > |t| = 0.7637 




Meta-analysis summary                     Number of studies =      4 
Random-effects model                      Heterogeneity: 
Method: REML                                          tau2 =  0.0005 
SE adjustment: Truncated Knapp-Hartung              I2 (%) =   47.36 
                                                        H2 =    1.90 
 
-------------------------------------------------------------------- 
            Study |    Effect Size    [95% Conf. Interval]  % Weight 
------------------+------------------------------------------------- 
     Barrett 2012 |          0.045       0.008       0.081     39.59 
     Barrett 2018 |          0.005      -0.009       0.020     59.52 
      Dykens 2014 |         -0.007      -0.419       0.405      0.79 
    Vinesett 2017 |         -0.137      -1.326       1.052      0.10 
------------------+------------------------------------------------- 
            theta |          0.021      -0.039       0.081 
-------------------------------------------------------------------- 
95% prediction interval for theta: [-0.108, 0.149] 
 
Test of theta = 0: t(3) = 1.10                   Prob > |t| = 0.3519 
Test of homogeneity: Q = chi2(3) = 3.87            Prob > Q = 0.2756 
 
  









Variance-covariance matrix = proportional .9*I(11)+.1*J(11,11,1) 
Method = reml                                  Number of dimensions    =    11 
Restricted log likelihood = -23.015115         Number of observations  =    30 
 
 Coef. Std. 
Err. 
z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int anxiety -.484 .085 -5.86 0.000 -.652 -.317 
1-6m anxiety -.503 .114 -4.39 0.000 -.728 -.278 
Post-int depression -.431 .068 -6.32 0.000 -.564 -.297 
1-6m depression -.436 .094 -4.60 0.000 -.622 -.250 
+6m depression -.247 .178 -1.39 0.166 -.597  .102 
Post-int distress -.442 .043 -10.21 0.000 -.527 -.357 
1-6m distress -.399 .055 -7.20 0.000 -.508 -.290 
+6m distress -.231 .110 -2.10 0.036 -.447 -.015 
Post-int wellbeing  .321 .058  5.51 0.000  .207  .436 
1-6m wellbeing  .353 .081  4.35 0.000  .194  .513 
+6m wellbeing  .280 .110  2.53 0.011  .063  .498 
 
Outcome              Estimate    95% Confidence Int.     95% Prediction Int. 
Post-int anxiety      -.484     -.652       -.317       -.846       -.123 
1-6m anxiety          -.503     -.728       -.278       -.897       -.109 
Post-int depression   -.431     -.564       -.297       -.776       -.085 
1-6m depression       -.436     -.622       -.250       -.806       -.065 
+6m depression        -.247     -.597        .102       -.730        .235 
Post-int distress     -.442     -.527       -.357       -.770       -.114 
1-6m distress         -.399     -.508       -.290       -.735       -.063 
+6m distress          -.231     -.447       -.015       -.619        .156 
Post-int wellbeing     .321      .207        .436       -.016        .659 
1-6m wellbeing         .353      .194        .513       -.003        .710 




Table 38. Sensitivity analysis excluding data from samples N<30. Comparison of MBPs with passive control 
groups: multivariate meta-analysis of anxiety, depression, distress, and wellbeing at post-intervention, (post-int), 
1-6 months follow-up, (1-6m) and 6+ months follow-up (+6m). The prediction intervals are shown in the second 
table. 










Variance-covariance matrix = proportional .9*I(11)+.1*J(11,11,1) 
Method = reml                                  Number of dimensions    =    11 
Restricted log likelihood = -127.22526         Number of observations  =    78 
 
 Coef. Std. 
Err. 
z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int anxiety -.700 .085 -8.21 0.000 -.867 -.533 
1-6m anxiety -.569 .126 -4.49 0.000 -.817 -.321 
Post-int depression -.437 .064 -6.81 0.000 -.563 -.311 
1-6m depression -.525 .101 -5.20 0.000 -.723 -.327 
+6m depression -.177 .319 -0.56 0.578 -.803  .448 
Post-int distress -.431 .048 -8.88 0.000 -.526 -.336 
1-6m distress -.430 .071 -6.01 0.000 -.571 -.290 
+6m distress -.153 .170 -0.90 0.368 -.488  .181 
Post-int wellbeing  .356 .073  4.87 0.000  .212  .499 
1-6m wellbeing  .349 .116  3.00 0.000  .121  .578 




Table 39. Sensitivity analysis setting estimate to +1 SE. Comparison of MBPs with passive control groups: 
multivariate meta-analysis of anxiety, depression, distress, and wellbeing at post-intervention, (post-int), 1-6 
months follow-up, (1-6m) and 6+ months follow-up (+6m).  










Variance-covariance matrix = proportional .3*I(8)+.7*J(8,8,1) 
Method = reml                                  Number of dimensions    =     8 
Restricted log likelihood = -23.852515         Number of observations  =    11 
 
 Coef. Std. 
Err. 
z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int anxiety -.542 .208 -2.61 0.009 -.950 -.134 
1-6m anxiety -.462 .205 -2.25 0.024 -.865 -.060 
Post-int depression -.409 .179 -2.28 0.022 -.761 -.058 
1-6m depression -.443 .183 -2.41 0.016 -.803 -.083 
Post-int distress -.362 .167 -2.17 0.030 -.690 -.035 
1-6m distress -.124 .191 -0.65 0.514 -.500  .250 
Post-int wellbeing  3.04 .666  4.57 0.000 1.737 4.350 
1-6m wellbeing  1.43 .541  2.64 0.008  .370  2.491 
 
  
Table 40. Sensitivity analysis setting estimate to +1 SE. Comparison of MBPs with active non-specific control 
groups: multivariate meta-analysis of anxiety, depression, distress, and wellbeing at post-intervention (post-int), 
1-6 months follow-up, (1-6m) and 6+ months follow-up (+6m).  








Variance-covariance matrix = proportional .9*I(11)+.1*J(11,11,1) 
Method = reml                                  Number of dimensions    =    11 
Restricted log likelihood = -16.032582         Number of observations  =    31 
 
 Coef. Std. 
Err. 
z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int anxiety   -.099   .078   -1.27   0.204   -.252    .054 
1-6m anxiety   .078   .138    0.57   0.568   -.191    .349 
Post-int depression  -.235   .058   -4.02   0.000   -.350   -.120 
1-6m depression  -.161   .077   -2.08   0.037   -.313   -.009 
+6m depression   .043  .141    0.31   0.759   -.233    .320 
Post-int distress  -.066   .050   -1.32   0.187   -.165    .032 
1-6m distress   .003   .071    0.04   0.965   -.137    .143 
+6m distress  -.052   .125   -0.42   0.677   -.297    .192 
Post-int wellbeing   .168   .068    2.46   0.014    .033    .302 
1-6m wellbeing   .028   .106    0.27   0.788   -.179    .236 
+6m wellbeing   .001   .180    0.01   0.991   -.351    .355 
 
  
Table 41. Sensitivity analysis setting estimate to +1 SE. Comparison of MBPs with active specific control groups: 
multivariate meta-analysis of anxiety, depression, distress, and wellbeing at post-intervention, (post-int), 1-6 
months follow-up, (1-6m) and 6+ months follow-up (+6m). 









Variance-covariance matrix = proportional .9*I(11)+.1*J(11,11,1) 
Method = reml                                  Number of dimensions    =    11 
Restricted log likelihood = -117.17977         Number of observations  =    78 
 
 Coef. Std. 
Err. 
z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int anxiety -.691 .080 -8.62 0.000 -.849 -.534 
1-6m anxiety -.567 .118 -4.78 0.000 -.799 -.334 
Post-int depression -.464 .060 -7.64 0.000 -.584 -.345 
1-6m depression -.545 .095 -5.72 0.000 -.732 -.358 
+6m depression -.199 .295 -0.67 0.500 -.779  .380 
Post-int distress -.461 .045 -10.07 0.000 -.551 -.371 
1-6m distress -.465 .067 -6.88 0.000 -.597 -.332 
+6m distress -.169 .159 -1.06 0.287 -.482  .142 
Post-int wellbeing  .332 .068  4.85 0.000  .197  .466 
1-6m wellbeing  .298 .108  2.74 0.006  .085  .512 
+6m wellbeing  .243 .176  1.38 0.167 -.101  .588 
 
Outcome               Estimate    95% Confidence Int.     95% Prediction Int. 
Post-int anxiety       -.691     -.849        -.534      -1.278     -.104 
1-6m anxiety           -.567     -.799        -.334      -1.179      .045 
Post-int depression    -.464     -.584        -.345      -1.042      .112 
1-6m depression        -.545     -.732        -.358      -1.141      .050 
+6m depression         -.199     -.779         .380      -1.015      .616 
Post-int distress      -.461     -.551        -.371      -1.033      .110 
1-6m distress          -.465     -.597        -.332      -1.045      .115 
+6m distress           -.169     -.482         .142       -.818      .478 
Post-int wellbeing      .332      .197         .466       -.249      .913 
1-6m wellbeing          .298      .085         .512       -.306      .903 






Table 42. Sensitivity analysis setting estimate to -1 SE. Comparison of MBPs with passive control groups: 
multivariate meta-analysis of anxiety, depression, distress, and wellbeing at post-intervention, (post-int), 1-6 
months follow-up, (1-6m) and 6+ months follow-up (+6m). The prediction intervals are shown in the second 
table. 
 










Variance-covariance matrix = proportional .3*I(8)+.7*J(8,8,1) 
Method = reml                                  Number of dimensions    =     8 
Restricted log likelihood = -23.23405          Number of observations  =    11 
 
 Coef. Std. 
Err. 
z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int anxiety -.564 .202 -2.79 0.005 -.960 -.167 
1-6m anxiety -.486 .199 -2.44 0.015 -.876 -.095 
Post-int depression -.443 .174 -2.55 0.011 -.785 -.102 
1-6m depression -.466 .178 -2.62 0.009 -.815 -.117 
Post-int distress -.394 .162 -2.43 0.015 -.712 -.076 
1-6m distress -.150 .186 -0.81 0.419 -.515  .214 
Post-int wellbeing 2.978 .660  4.51 0.000 1.682 4.273 
1-6m wellbeing 1.382 .534  2.58 0.010  .334 2.429 
 
Outcome                   Estimate    95% Confidence Int.     95% Prediction Int. 
Post-int anxiety           -.564     -.960       -.167         -1.679      .551 
1-6m anxiety               -.486     -.876       -.095         -1.598      .626 
Post-int depression        -.443     -.785       -.102         -1.534      .646 
1-6m depression            -.466     -.815       -.117         -1.560      .627 
Post-int distress          -.394     -.712       -.076         -1.475      .686 
1-6m distress              -.150     -.515        .214         -1.251      .950 
Post-int wellbeing         2.978     1.682       4.273          1.169     4.786 




Table 43. Sensitivity analysis setting estimate to -1 SE. Comparison of MBPs with active non-specific control 
groups: multivariate meta-analysis of anxiety, depression, distress, and wellbeing at post-intervention, (post-int), 
1-6 months follow-up, (1-6m) and 6+ months follow-up (+6m). The prediction intervals are shown in the second 
table. 








Variance-covariance matrix = proportional .9*I(11)+.1*J(11,11,1) 
Method = reml                                  Number of dimensions    =    11 
Restricted log likelihood = -18.460193         Number of observations  =    31 
 
 Coef. Std. 
Err. 
z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int anxiety -.135 .084 -1.61 0.107 -.300 .029 
1-6m anxiety .064 .148 0.44 0.663 -.227 .356 
Post-int depression -.250 .062 -4.02 0.000 -.372 -.128 
1-6m depression -.172 .082 -2.10 0.036 -.334 -.011 
+6m depression -.137 .149 -0.92 0.360 -.431 .156 
Post-int distress -.084 .053 -1.58 0.115 -.189 .020 
1-6m distress -.023 .076 -0.31 0.759 -.172 .125 
+6m distress -.001 .132 -0.01 0.991 -.260 .257 
Post-int wellbeing .168 .073 2.30 0.021 .025 .312 
1-6m wellbeing .028 .113 0.25 0.805 -.194 .250 
+6m wellbeing -.007 .194 -0.04 0.970 -.387 .372 
 
  
Table 44. Sensitivity analysis setting estimate to -1 SE. Comparison of MBPs with active specific control groups: 
multivariate meta-analysis of anxiety, depression, distress, and wellbeing at post-intervention, (post-int), 1-6 
months follow-up, (1-6m) and 6+ months follow-up (+6m).  
 










Variance-covariance matrix = proportional .9*I(11)+.1*J(11,11,1) 
Method = reml                                  Number of dimensions    =    11 
Restricted log likelihood = -85.029503         Number of observations  =    55 
 
 Coef. Std. 
Err. 
z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int anxiety -.646 .110 -5.86 0.000 -.863 -.430 
1-6m anxiety -.814 .182 -4.46 0.000 -1.172 -.456 
Post-int depression -.472 .076 -6.15 0.000 -.622 -.321 
1-6m depression -.485 .120 -4.02 0.000 -.722 -.249 
+6m depression -.177 .300 -0.59 0.555 -.766  .411 
Post-int distress -.415 .055 -7.54 0.000 -.523 -.307 
1-6m distress -.383 .080 -4.74 0.000 -.541 -.224 
+6m distress -.151 .161 -0.93 0.351 -.468  .166 
Post-int wellbeing  .371 .074  4.96 0.000  .224  .517 
1-6m wellbeing  .322 .110  2.92 0.004  .105  .539 
+6m wellbeing  .254 .178  1.43 0.154 -.095  .604 
 
Outcome                  Estimate    95% Confidence Int.     95% Prediction Int. 
Post-int anxiety          -.646     -.863        -.430       -1.266      -.027 
1-6m anxiety              -.814    -1.172        -.456       -1.498      -.129 
Post-int depression       -.472     -.622        -.321       -1.070       .126 
1-6m depression           -.485     -.722        -.249       -1.112       .141 
+6m depression            -.177     -.766         .411       -1.013       .657 
Post-int distress         -.415     -.523        -.307       -1.004       .173 
1-6m distress             -.383     -.541        -.224        -.983       .217 
+6m distress              -.151     -.468         .166        -.814       .512 
Post-int wellbeing         .371      .224         .517        -.226       .968 
1-6m wellbeing             .322      .105         .539        -.296       .942 






Table 45 Sensitivity analysis excluding studies with unclear teacher competence. Comparison of MBPs with 
passive control groups: multivariate meta-analysis of anxiety, depression, distress, and wellbeing at post-
intervention, (post-int), 1-6 months follow-up, (1-6m) and 6+ months follow-up (+6m). The prediction intervals 
are shown in the second table. 










Variance-covariance matrix = proportional .3*I(8)+.7*J(8,8,1) 
Method = reml                                  Number of dimensions    =     8 
Restricted log likelihood = -23.080973         Number of observations  =    10 
 
 Coef. Std. 
Err. 
z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int anxiety -.542 .211 -2.56 0.011 -.957 -.126 
1-6m anxiety -.462 .207 -2.22 0.026 -.869 -.054 
Post-int depression -.414 .183 -2.26 0.024 -.773 -.054 
1-6m depression -.443 .186 -2.38 0.017 -.808 -.077 
Post-int distress -.357 .176 -2.03 0.042 -.703 -.012 
1-6m distress -.123 .194 -0.64 0.525 -.505  .257 
Post-int wellbeing 3.046 .671  4.54 0.000 1.731 4.362 
1-6m wellbeing 1.432 .543  2.64 0.008  .367 2.497 
 
Outcome                Estimate    95% Confidence Int.     95% Prediction Int. 
Post-int axiety          -.542     -.957       -.126       -1.725      .641 
1-6m anxiety             -.462     -.869       -.054       -1.641      .717 
Post-int depression      -.414     -.773       -.054       -1.571      .743 
1-6m depression          -.443     -.808       -.077       -1.603      .717 
Post-int distress        -.357     -.703       -.012       -1.509      .793 
1-6m distress            -.123     -.505        .257       -1.291     1.043 
Post-int wellbeing      3.046      1.731       4.362        1.161     4.932 







Table 46. Sensitivity analysis excluding studies with unclear teacher competence. Comparison of MBPs with 
active non-specific control groups: multivariate meta-analysis of anxiety, depression, distress, and wellbeing at 
post-intervention, (post-int), 1-6 months follow-up, (1-6m) and 6+ months follow-up (+6m). 









Variance-covariance matrix = proportional .9*I(11)+.1*J(11,11,1) 
Method = reml                                  Number of dimensions    =    11 
Restricted log likelihood = -11.083879         Number of observations  =    22 
 
 Coef. Std. 
Err. 
z P>|z| [95% Conf. 
Interval] 
 
Overall mean       
Post-int anxiety -.058 .101 -0.58 0.562 -.257 .139 
1-6m anxiety .388 .195 1.99 0.047 .005 .770 
Post-int depression -.267 .066 -4.01 0.000 -.398 -.136 
1-6m depression -.207 .084 -2.45 0.014 -.373 -.041 
+6m depression -.055 .138 -0.40 0.687 -.326 .215 
Post-int distress -.129 .057 -2.24 0.025 -.241 -.016 
1-6m distress -.038 .081 -0.47 0.638 -.197 .121 
+6m distress -.034 .122 -0.28 0.776 -.275 .205 
Post-int wellbeing .159 .081 1.94 0.052 -.001 .319 
1-6m wellbeing .004 .138 0.03 0.975 -.267 .276 
+6m wellbeing -.009 .175 -0.05 0.959 -.353 .335 
  
Table 47. Sensitivity analysis excluding studies with unclear teacher competence. Comparison of MBPs with 
active specific control groups: multivariate meta-analysis of anxiety, depression, distress, and wellbeing at post-
intervention, (post-int), 1-6 months follow-up, (1-6m) and 6+ months follow-up (+6m). 






Variance-covariance matrix = proportional .9*I(4)+.1*J(4,4,1) 
Method = reml                                  Number of dimensions    =     4 
Restricted log likelihood = -38.844293         Number of observations  =    31 
-------------------------------------------------------------------------------- 
                 |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-----------------+-------------------------------------------------------------- 
1-6m anxiety     | 
Selective MBP    |   -.601       .360        -1.67   0.095    -1.307     .103 
Indicated MBP    |   -1.123      .418        -2.68   0.007    -1.943    -.303 
USA studies      |   1.099       .500         2.20   0.028      .119    2.080 
Contact hours    |    .020       .031         0.65   0.514     -.041     .083 
Physical exercise|   -.716       .476        -1.50   0.133    -1.651     .218 
         _cons   |   -.910       .525        -1.73   0.083    -1.940     .118 
-----------------+-------------------------------------------------------------- 
1-6m depression  | 
Selective MBP    |   -1.070      .338        -3.16   0.002    -1.734    -.406 
Indicated MBP    |    -.841       .343        -2.45  0.014    -1.515    -.167 
USA studies      |    1.084       .282        3.84   0.000      .530    1.637 
Contact hours    |    .045       .018         2.48   0.013      .009     .081 
Psychoeducation  |   -.550       .383        -1.44   0.151    -1.302     .201 
Physical exercise| -.961       .403        -2.38   0.017    -1.752    -.169 
         _cons   |  -1.027       .415        -2.48   0.013    -1.841    -.214 
-----------------+-------------------------------------------------------------- 
1-6m distress    | 
Selective MBP    |  -.063       .167        -0.38   0.703    -.392        .264 
Indicated MBP    |   .099       .299         0.33   0.740    -.487        .685 
USA studies      |   .244       .230         1.06   0.291    -.208        .696 
Contact hours    |   .001       .016         0.09   0.928    -.031        .034 
Psychoeducation  |  -.368       .248        -1.49   0.137    -.855        .117 
Physical exercise|   .115       .224         0.51   0.607    -.323        .554 
Arts             |  -.744       .525        -1.42   0.157    -1.774       .286 
         _cons   |  -.534       .313        -1.71   0.088    -1.148       .0795 
-----------------+-------------------------------------------------------------- 
1-6m wellbeing   | 
Selective MBP    |   .156       .371         0.42   0.673    -.571        .883 
USA studies      |  -.397       .813        -0.49   0.626    -1.991      1.197 
Contact hours    |  -.006       .079        -0.08   0.939    -.1621       .149 
Psychoeducation  |   .355      1.307         0.27   0.786    -2.207      2.918 
Physical exercise|   .247       .553         0.45   0.655    -.837       1.331 
Arts             |   .689      1.156         0.60   0.551    -1.577      2.956 





Table 48. Multivariate Meta-regression. Comparison of MBPs with passive control groups, outcomes at 1-6 months 
follow-up. USA studies= studies from the USA; selective MBP=selective intervention; indicated MBP=indicated 
intervention; Psychoeducation= adding psychoeducation component and/or non-meditative psychological exercises; 
Physical exercise= adding physical exercise component; Arts= adding arts component. 













Random-effects meta-regression                      Number of obs  =        11 
Method: REML                                        Residual heterogeneity: 
SE adjustment: Truncated Knapp-Hartung                          tau2 = 1.5e-07 
                                                              I2 (%) =    0.00 
                                                                  H2 =    1.00 
                                                       R-squared (%) =  100.00 
                                                    Model F(6,4)   =      7.23 
                                                    Prob > F       =    0.0381 
------------------------------------------------------------------------------- 
     _meta_es |   Coef.   Std. Err.      t    P>|t|     [95% Conf. Interval] 
--------------+---------------------------------------------------------------- 
Selective MBP |   .168     .041        4.10   0.015        .054       .283 
Indicated MBP |  -.153     .264       -0.58   0.592       -.886       .579 
USA studies   |   .057     .156        0.37   0.732       -.375       .490 
Contact hours |  -.023     .014       -1.62   0.181       -.062       .016 
Psychoeducati |      0  (omitted) 
Physical exer |   .510     .198        2.57   0.062       -.040       1.061 
Other meditat |      0  (omitted) 
Other/unclear |   .502     .247        2.03   0.112       -.183       1.188 
        _cons |   .010     .204        0.05   0.961       -.558        .579 
------------------------------------------------------------------------------- 
Test of residual homogeneity: Q_res = chi2(4) =  1.30    Prob > Q_res = 0.8616 
 
Table 49. Meta-regression. Comparison of MBPs with active specific control groups, outcome distress at 1-6 months 
follow-up. Selective MBP=selective intervention; indicated MBP=indicated intervention; Psychoeducation= adding 
psychoeducation component and/or non-meditative psychological exercises; Physical exercise= adding physical 
exercise component; Other meditation= adding other types meditation component; Arts= adding arts component. 
Psychoeducation and other meditation are omitted because of collinearity. 




Fig 1. Funnel plot for univariate meta-analysis for the depression outcome at 1-6 months post-intervention for MBPs 
compared with passive controls. 
  




Fig 2. Funnel plot for univariate meta-analysis distress 1-6 months post-intervention compared with passive controls.  




Fig 3. Funnel plot for univariate meta-analysis distress 1-6 months post-intervention compared with active specific controls. 
